Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: A subgroup analysis of the CHANCE trial

Stroke and Vascular Neurology

Volumn 1, Issue 2, 2016, Pages 29-36

  Wang, David ^a   Gui, Li ^b   Dong, Yi ^c   Li, Hao ^d   Li, Shujuan ^e   Zheng, Huaguang ^d   Wang, Anxin ^d   Meng, Xia ^d   Liu, Li Ping ^d   Wang, Yi Long ^d   Wang, Guangyao ^d   Jing, Jing ^d   Li, Zixiao ^d   Zhao, Xing Quan ^d   Wang, Yong Jun ^d  

^a UNIVERSITY OF ILLINOIS   (United States)

^b SOUTHWEST HOSPITAL   (China)

^c FUDAN UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ADVERSE EVENT; AGED; BLEEDING; BRAIN ISCHEMIA; CHINA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; ASPIRIN; CHINA; CLOPIDOGREL; DOUBLE-BLIND METHOD; DUAL ANTI-PLATELET THERAPY; HEMORRHAGE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; ISCHEMIC STROKE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85007231552     PISSN: 20598688     EISSN: 20598696     Source Type: Journal    
DOI: 10.1136/svn-2016-000008     Document Type: Article

References (20)

1. Wang Y, Wang Y, Zhao X, et al Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013; 369: 11-19.
2. Wang Y, Johnston SC, CHNANCE Investors. Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J 2010; 160: 380-6.e1.
3. Kernan WN, Ovbiagele B, Black HR, et al, American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 2160-236.
4. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993; 329: 673-82.
5. Yusuf S, Zhao F, Mehta SR, et al, Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502.
6. Bhatt DL, Fox KA, Hacke W. et al., CHARISMA Investigators. Clopidogrel and aspirin vs aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706-17.
7. Benavente OR, Hart RG, McClure LA, et al, SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012; 367: 817-25.
8. Kennedy J, Hill MD, Ryckborst KJ, et al Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007; 6: 961-9.
9. Diener HC, Bogousslavsky J, Brass LM, et al Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331-7.
10. Wong KS, Chen C, Fu J, et al Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010; 9: 489-97.
11. Kwon SU, Hong KS, Kang DW Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke 2011; 42: 2883-90.
12. Chimowitz MI, Lynn MJ, Derdeyn CP, et al, SAMMPRIS Trial Investigators. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365: 993-1003.
13. Markus HS, Droste DW, Kaps M, et al Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005; 111: 2233-40.
14. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996; 16: 1329-39.
15. Miners JO. Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid. Clin Pharmacokinet 1989; 17: 327-44.
16. Bhindi R, Ormerod O, Newton J, et al Interaction between statins and clopidogrel: is there anything clinically relevant? QJM 2008; 101: 915-25.
17. Ganesan S, Williams C, Maslen CL, et al Clopidogrel variability: role of plasma protein binding alterations. Br J Clin Pharmacol 2013; 75: 1468-77.
18. Chen ZM, Jiang LX, Chen YP, et al, COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1607-21.
19. Vogel HG, Maas J, Gebauer A. Drug discovery and evaluation: methods in clinical pharmacology. New York, NY: Springer, 2010.
20. Cruden NL, Morch K, Wong DR, et al Clopidogrel loading dose and bleeding outcome in patient undergoing urgent coronary artery bypass grafting. Am Heart J 2011; 161: 404-10.